In making selections for Super Doctors, MSP Communications employs a rigorous multi-step process designed to identify healthcare providers who have attained a high degree of peer recognition and professional achievement. Super Doctors is a selective yet diverse listing of outstanding doctors, representing consumer-oriented medical specialties.
Today, the U.S. Food and Drug Administration is announcing the supplemental approval of Rexulti (brexpiprazole) oral tablets for the treatment of agitation associated with dementia due to Alzheimer’s disease. This is the first FDA-approved treatment option for this indication.
Early Riser or Night Owl? New Study May Help to Explain the Difference
Some people are early risers, wide awake at the crack of dawn. Others are night owls who can’t seem to get to bed until well after midnight and prefer to sleep in. Why is this?
Study Shows How Taking Short Breaks May Help Our Brains Learn New Skills
NIH scientists discover that the resting brain repeatedly replays compressed memories of what was just practiced.
AHA alert on COVID-19 vaccine misinformation
The American Heart Association warns of misinformation about the COVID-19 vaccine spreading via email and social media by using fraudulent AHA logos.
Super Doctors identifies top doctors as selected by their peers and the independent research of MSP Communications. Please note: Doctors cannot pay to be included on Super Doctors® listings nor are they paid to provide input.
Super Doctors is published online and also in print as a special advertising section in leading newspapers and city and regional magazines.
Super Doctors appears in top city and regional publications around the U.S.: